Stocks
ADARx Pharmaceuticals, Inc.ADRX
NASDAQHealthcareBiotechnology$17.68
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing ribonucleic acid (RNA) therapies for genetic and rare diseases. Its lead candidates target complement-mediated disorders and cardiovascular conditions, with early-stage trials underway. Investors track ADRX for its potential in the RNA therapeutics space, though the company has yet to generate revenue.
52W Range: $16.61-$23.21
Congressional Interest in ADARx Pharmaceuticals, Inc. (ADRX)
No congressional trades have been disclosed for ADARx Pharmaceuticals, Inc. (ADRX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ADRX?
No congressional trades found for this stock.